Anabolic Steroids
[3,2-c]Furazan-5α-androstan-17β-ol[3,2-c]Furazan-5α-androstan-17β-ol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.[3,2-c]Pyrazole-androst-4-en-17β-ol[3,2-c]Pyrazole-androst-4-en-17β-ol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.1-Androstenediol (3α,17β)1-Androstenediol (3α,17β) is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.1-Androstenediol (3β,17β)1-Androstenediol (3β,17β) is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.1-Androstenedione1-Androstenedione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.1-Testosterone1-Testosterone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.13β-Ethyl-17β-hydroxygon-4-en-3-one13β-Ethyl-17β-hydroxygon-4-en-3-one is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17α-Methyl-3α,17β-dihydroxy-5α-androstane17α-Methyl-3α,17β-dihydroxy-5α-androstane is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17α-Methyl-3β,17β-dihydroxy-5α-androstane17α-Methyl-3β,17β-dihydroxy-5α-androstane is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17α-Methyl-3β,17β-dihydroxyandrost-4-ene17α-Methyl-3β,17β-dihydroxyandrost-4-ene is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17α-Methyl-4-hydroxynandrolone17α-Methyl-4-hydroxynandrolone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17α-Methyl-5α-androstan-17β-ol17α-Methyl-5α-androstan-17β-ol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17α-Methyl-androst-2-ene-3,17β-diol17α-Methyl-androst-2-ene-3,17β-diol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17α-Methyl-androsta-1,4-diene-3,17β-diol17α-Methyl-androsta-1,4-diene-3,17β-diol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17α-Methyl-androstan-3-hydroxyimine-17β-ol17α-Methyl-androstan-3-hydroxyimine-17β-ol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17β-Hydroxy-androstano[2,3-d]isoxazole17β-Hydroxy-androstano[2,3-d]isoxazole is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.17β-Hydroxy-androstano[3,2-c]isoxazole17β-Hydroxy-androstano[3,2-c]isoxazole is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.19-Nor-4-androstenediol (3α,17β)19-Nor-4-androstenediol (3α,17β) is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.19-Nor-4-androstenediol (3β,17β)19-Nor-4-androstenediol (3β,17β) is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.19-Nor-4-androstenedione19-Nor-4-androstenedione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.19-Nor-4,9(10)-androstadienedione19-Nor-4,9(10)-androstadienedione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.19-Nor-5-androstenediol (3α,17β)19-Nor-5-androstenediol (3α,17β) is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.19-Nor-5-androstenediol (3β,17β)19-Nor-5-androstenediol (3β,17β) is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.19-Nor-5-androstenedione19-Nor-5-androstenedione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.3α,17β-Dihydroxy-5α-androstane3α,17β-Dihydroxy-5α-androstane is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.3β-Hydroxy-estra-4,9,11-trien-17-one3β-Hydroxy-estra-4,9,11-trien-17-one is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.3β,17β-Dihydroxy-5α-androstane3β,17β-Dihydroxy-5α-androstane is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.4-Androstenediol4-Androstenediol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.4-Androstenedione4-Androstenedione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.4-Hydroxy-19-nortestosterone4-Hydroxy-19-nortestosterone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.4-Hydroxy-androst-4-ene-3,17-dione4-Hydroxy-androst-4-ene-3,17-dione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.4-Hydroxytestosterone4-Hydroxytestosterone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.5-Androstenediol5-Androstenediol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.5-Androstenedione5-Androstenedione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.5α-Androstan-3,17-dione5α-Androstan-3,17-dione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.5α-Androstan-3,6,17-trione5α-Androstan-3,6,17-trione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.6-Bromo-androsta-1,4-diene-3,17-dione6-Bromo-androsta-1,4-diene-3,17-dione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.6-Bromo-androstan-3,17-dione6-Bromo-androstan-3,17-dione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.6α-Methyl-androst-4-ene-3,17-dione6α-Methyl-androst-4-ene-3,17-dione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.BolasteroneBolasterone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.BoldenoneAn anabolic steroid primarily associated with veterinary use. Human performance claims are not equivalent to established therapeutic evidence.BoldioneBoldione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.CalusteroneCalusterone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.ClostebolClostebol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.DehydrochloromethyltestosteroneAn oral chlorinated anabolic steroid known historically as Oral Turinabol and strongly associated with sports-doping history.DesoxymethyltestosteroneA designer anabolic steroid also known as madol. Human efficacy and safety data are sparse compared with established prescription androgens.Dihydrotestosterone (DHT)A naturally occurring androgen formed from testosterone by 5α-reductase. It is a high-affinity androgen-receptor agonist and cannot aromatize to estradiol.DrostanoloneA DHT-derived anabolic steroid with historical medical use. Modern performance use is largely outside approved medicine and should be interpreted through class-level AAS risk data.Epithio-17α-methyl-androstanolEpithio-17α-methyl-androstanol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.EthylestrenolEthylestrenol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.FluoxymesteroneA potent 17α-alkylated androgen with historical therapeutic use. Its pharmacology is androgen-receptor mediated; nonmedical exposure can carry substantial hepatic, lipid, cardiovascular and endocrine risk.FormeboloneFormebolone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.FurazabolFurazabol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.MestanoloneMestanolone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.MesteroloneAn orally active DHT-derived androgen used medically in some countries but not broadly approved in the United States. It is androgenic and can suppress endogenous gonadal signaling.MethandienoneAn orally active 17α-alkylated anabolic steroid widely known from historical performance-enhancement use. It is not an FDA-approved dietary supplement and carries the class risks of anabolic-androgenic steroids.MethandriolMethandriol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.MethasteroneA designer 17α-alkylated anabolic steroid also known as methyldrostanolone or Superdrol. Case literature and class pharmacology raise particular concern for liver and lipid effects.MethenoloneA DHT-derived anabolic steroid with historical medical use in some markets. Evidence for nonmedical physique claims is not the same as evidence for clinical benefit.Methyl-1-testosteroneMethyl-1-testosterone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.MethyldienoloneMethyldienolone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.MethyltestosteroneMethyltestosterone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.MethyltrienoloneMethyltrienolone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.MiboleroneMibolerone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.NandroloneA 19-nortestosterone anabolic-androgenic steroid with historical and limited medical use in some jurisdictions. Its endocrine, reproductive, cardiovascular and lipid effects are important when interpreting nonmedical use.NorbolethoneNorbolethone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.NorclostebolNorclostebol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.NorethandroloneNorethandrolone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.NormethandroloneNormethandrolone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.OxandroloneAn orally active 17α-alkylated anabolic steroid that has had approved medical uses. Oral alkylation improves bioavailability but is also relevant to hepatic and lipid risk.OxymesteroneOxymesterone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.OxymetholoneA potent orally active anabolic steroid historically used for selected anemias. It is associated with clinically important hepatic, lipid and endocrine adverse effects.ProstanozolProstanozol is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.StanozololA synthetic anabolic steroid with past medical use and extensive history in doping. It is a 17α-alkylated oral/injectable agent and can adversely affect liver enzymes and lipids.StenboloneStenbolone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.TestolactoneTestolactone is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.TestosteroneEndogenous androgen and the reference molecule for anabolic-androgenic pharmacology. Prescription testosterone products are used for specific medical indications, while nonmedical supraphysiologic exposure carries materially different risk.Tetrahydrogestrinone (THG)Tetrahydrogestrinone (THG) is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.TrenboloneA potent synthetic 19-nor anabolic steroid used in veterinary contexts rather than approved human therapy in the United States. Human performance use is unsupported by approved clinical dosing and carries substantial uncertainty and risk.TrendioneTrendione is listed in current U.S. federal Schedule III regulations as an anabolic steroid or covered anabolic-steroid substance. Compound-specific human evidence may be limited or historical.
SARMs
ACP-105ACP-105 is sarm candidate. The evidence base is mostly preclinical, and it is not an FDA-approved bodybuilding product.Andarine (S-4)Andarine (S-4) is true sarm candidate. The evidence base is predominantly preclinical / limited human literature, and it is not an FDA-approved bodybuilding product.Enobosarm (Ostarine / GTx-024)Enobosarm (Ostarine / GTx-024) is true nonsteroidal sarm. The evidence base is human randomized trials, and it is not an FDA-approved bodybuilding product.GLPG0492GLPG0492 is true sarm candidate. The evidence base is early human/preclinical development, and it is not an FDA-approved bodybuilding product.GSK2881078GSK2881078 is true nonsteroidal sarm. The evidence base is human phase 1/2 studies, and it is not an FDA-approved bodybuilding product.LGD-4033 (Ligandrol)LGD-4033 (Ligandrol) is true nonsteroidal sarm. The evidence base is human placebo-controlled study, and it is not an FDA-approved bodybuilding product.LY2452473 (OPK-88004)LY2452473 (OPK-88004) is true sarm candidate. The evidence base is human clinical development, and it is not an FDA-approved bodybuilding product.MK-0773MK-0773 is true nonsteroidal sarm. The evidence base is human randomized trial, and it is not an FDA-approved bodybuilding product.PF-06260414PF-06260414 is true sarm candidate. The evidence base is early clinical development, and it is not an FDA-approved bodybuilding product.RAD140 (Testolone / Vosilasarm)RAD140 (Testolone / Vosilasarm) is true nonsteroidal sarm. The evidence base is first-in-human oncology study, and it is not an FDA-approved bodybuilding product.S-23S-23 is true sarm candidate. The evidence base is predominantly preclinical, and it is not an FDA-approved bodybuilding product.YK-11YK-11 is marketed as a sarm; evidence is unusually limited. The evidence base is cell/preclinical evidence; poor human evidence, and it is not an FDA-approved bodybuilding product.
SARM-Adjacent Compounds
Cardarine (GW501516)Cardarine (GW501516) is commonly grouped with SARMs online but is mechanistically different.Ibutamoren (MK-677)Ibutamoren (MK-677) is commonly grouped with SARMs online but is mechanistically different.SR9009 (Stenabolic)SR9009 (Stenabolic) is commonly grouped with SARMs online but is mechanistically different.
Peptides & Peptide Hormones
AOD-9604AOD-9604 is classified here as modified growth-hormone fragment. Evidence level: Clinical development history but limited evidence for current fitness claims.Blended “research peptide” productsBlended “research peptide” products is classified here as mixtures of two or more peptides. Evidence level: Usually no direct evidence for the exact mixture.BPC-157BPC-157 has a large preclinical literature but very limited human evidence; current reviews emphasize that clinical validation is still inadequate.Bremelanotide (PT-141)Bremelanotide (PT-141) is classified here as melanocortin receptor agonist peptide. Evidence level: High for its approved indication; not a performance drug.CJC-1295CJC-1295 is classified here as long-acting ghrh analogue. Evidence level: Limited human trials.Epitalon (Epithalon)Epitalon (Epithalon) is classified here as synthetic tetrapeptide research compound. Evidence level: Limited and heterogeneous human literature.GHK-CuGHK-Cu is classified here as copper-binding tripeptide. Evidence level: Human topical/cosmetic literature plus preclinical work; systemic performance evidence is weak.GHRP-2 (Pralmorelin)GHRP-2 (Pralmorelin) is classified here as growth-hormone-releasing peptide. Evidence level: Human endocrine/pharmacology studies exist.GHRP-6GHRP-6 is classified here as growth-hormone-releasing peptide. Evidence level: Older human endocrine studies.hCG (Human Chorionic Gonadotropin)hCG (Human Chorionic Gonadotropin) is classified here as glycoprotein hormone. Evidence level: High for specific reproductive/endocrine indications.HexarelinHexarelin is classified here as growth-hormone-releasing peptide. Evidence level: Small human studies plus preclinical work.IGF-1 / MecaserminIGF-1 / Mecasermin is classified here as peptide growth factor. Evidence level: High for selected approved endocrine indications; performance claims are a separate question.InsulinInsulin is an essential medical peptide hormone. Misuse outside diabetes care can cause rapid, severe and potentially fatal hypoglycemia.IpamorelinIpamorelin is classified here as growth-hormone secretagogue / ghrelin-receptor agonist peptide. Evidence level: Limited human pharmacology studies.KisspeptinKisspeptin is classified here as hypothalamic reproductive neuropeptide. Evidence level: Human endocrine and fertility research.Mechano Growth Factor (MGF / IGF-1Ec)Mechano Growth Factor (MGF / IGF-1Ec) is classified here as igf-1 splice-variant concept / research peptide products. Evidence level: Mostly mechanistic and preclinical for marketed peptide products.Melanotan IIMelanotan II is classified here as synthetic melanocortin peptide. Evidence level: Limited clinical research; substantial unregulated-market use.MOTS-cMOTS-c is classified here as mitochondrial-derived peptide. Evidence level: Early/preclinical and emerging human research.RetatrutideRetatrutide is an investigational triple receptor agonist with substantial weight-loss effects in phase 2 research and ongoing later-stage development.SemaglutideSemaglutide is classified here as glp-1 receptor agonist peptide. Evidence level: High — multiple phase 3 trials and approved indications.SermorelinSermorelin is classified here as ghrh(1-29) analogue. Evidence level: Historical clinical use and endocrine research.Somatropin (Human Growth Hormone)Somatropin (Human Growth Hormone) is classified here as recombinant human peptide hormone. Evidence level: High for approved GH indications.TesamorelinTesamorelin is classified here as ghrh analogue. Evidence level: High for its approved HIV-associated lipodystrophy indication.Thymosin alpha-1Thymosin alpha-1 is classified here as immune-modulating peptide. Evidence level: Clinical research and approvals vary internationally by indication.Thymosin beta-4 / TB-500Thymosin beta-4 / TB-500 is classified here as regenerative peptide/protein fragment category. Evidence level: Preclinical and selected clinical programs for thymosin beta-4; TB-500 products are not interchangeable with trial formulations.TirzepatideTirzepatide is classified here as dual gip/glp-1 receptor agonist peptide. Evidence level: High — phase 3 obesity/diabetes programs and approved indications.